1QDX Stock Overview

Provides diagnostic testing and services in the United States and internationally. More details

1QDX fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	2/6
Financial Health	3/6
Dividends	4/6

Rewards

Trading at 45.5% below our estimate of its fair value

Earnings are forecast to grow 9.79% per year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Quest Diagnostics Incorporated Competitors

Amplifon

BIT:AMP

€3.9b

DiaSorin

BIT:DIA

€5.3b

Labcorp Holdings

NYSE:LH

US$20.7b

Fresenius Medical Care

XTRA:FME

€13.3b

Price History & Performance

Summary of share price highs, lows and changes for Quest Diagnostics
Historical stock prices
Current Share Price	US$156.05
52 Week High	US$0
52 Week Low	US$0
Beta	0.78
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0.81%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	1QDX	IT Healthcare	IT Market
7D	0.8%	2.8%	2.5%
1Y	n/a	17.0%	12.1%

Return vs Industry: Insufficient data to determine how 1QDX performed against the Italian Healthcare industry.

Return vs Market: Insufficient data to determine how 1QDX performed against the Italian Market.

Price Volatility

Is 1QDX's price volatile compared to industry and market?
1QDX volatility
1QDX Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.6%
Market Average Movement	5.3%
10% most volatile stocks in IT Market	8.8%
10% least volatile stocks in IT Market	3.3%

Stable Share Price: 1QDX's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1QDX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1967	50,500	Jim Davis	www.questdiagnostics.com

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.

Quest Diagnostics Incorporated Fundamentals Summary

How do Quest Diagnostics's earnings and revenue compare to its market cap?
1QDX fundamental statistics
Market cap	€17.57b
Earnings (TTM)	€788.97m
Revenue (TTM)	€8.98b

22.3x

P/E Ratio

2.0x

P/S Ratio

Is 1QDX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1QDX income statement (TTM)
Revenue	US$10.16b
Cost of Revenue	US$6.80b
Gross Profit	US$3.36b
Other Expenses	US$2.46b
Earnings	US$892.00m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	7.99
Gross Margin	33.04%
Net Profit Margin	8.78%
Debt/Equity Ratio	83.3%

How did 1QDX perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

38%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 06:09
End of Day Share Price	2025/05/02 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quest Diagnostics Incorporated is covered by 47 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
Brian Kemp Dolliver	Avondale Partners
Eric Coldwell	Baird